aptaTargets
PrivateLast Round
Grant
Mar 11, 2024
Total Funding Raised
$16.43M
Company Overview
aptaTargets is a biopharmaceutical company that develops aptamer-based therapeutics intended to treat acute conditions driven by inflammation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
aptaTargets Comparables
Compare aptaTargets with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avilex Pharma | 87% | |
| NoNO Inc. | 84% | |
| FreeOx Biotech | 80% |
aptaTargets Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 11, 2024 | ||||
| Grant | Feb 19, 2024 | ||||
| Grant | Jan 22, 2024 | ||||
| Series B | Oct 14, 2020 | ||||
| Grant | Jul 1, 2020 | ||||
Series A | May 17, 2017 |
Key People
Founding team and executive leadership
aptaTargets Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Inveready | Series B, Series A |
| Community of Madrid | Grant |
| Criteria Capital Risc | Series A |
| Center for Technological Development and Innovation | Series B |
| Spanish Government (Ministry of Science) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2024
$2.7M grant awarded by the European Innovation Council.
- Feb 19, 2024
Secured $2M in grant funding from the Community of Madrid.
aptaTargets Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about aptaTargets's valuation, stock price, and market status.
Is aptaTargets a public or private company?
aptaTargets is a private company.
What is the current stock price of aptaTargets?
aptaTargets is a private company with no public stock price. No recent secondary market data is available.
How much is aptaTargets worth (valuation)?
Valuation information for aptaTargets is not publicly available.
Can I buy aptaTargets stock?
aptaTargets shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was aptaTargets's last funding round?
aptaTargets's most recent funding round was Grant on March 11, 2024.
Who are the main investors in aptaTargets?
Key investors in aptaTargets include European Innovation Council, Inveready, Community of Madrid, Caixa Capital Risc, Center for Technological Development and Innovation.
Will aptaTargets IPO soon?
No public IPO plans have been announced for aptaTargets.
How can I track aptaTargets secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor aptaTargets's secondary market activity and sign up for updates.